# Cerebral rheumatoid vasculitis: an integrated analysis of case presentation, literature review, and prognostic stratification

## TL;DR

This study improves understanding and management of cerebral rheumatoid vasculitis, a rare RA complication, by analyzing case data and literature.

## Contribution

The study introduces a CRV diagnostic workflow and shows improved outcomes with immunosuppressants and corticosteroids.

## Key findings

- Mortality from CRV dropped significantly after the 1980s, with an odds ratio of 33.07.
- Combining immunosuppressants and corticosteroids achieved 81.8% efficacy in treating CRV.
- The study developed a diagnostic workflow to aid early detection of CRV.

## Abstract

This study integrated a comprehensive literature review spanning from 1951 to 2025 with a histologically confirmed case of cerebral rheumatoid vasculitis (CRV) in order to improve the management of this rare and severe complication of rheumatoid arthritis (RA). By analyzing 37 CRV cases, we observed a striking decline in mortality after the 1980s, with an odds ratio (OR) of 33.07. The combination of immunosuppressants and corticosteroids significantly enhanced treatment outcomes, showing 81.8% efficacy compared to a 63.6% mortality rate without immunosuppressants. Based on these findings, we developed the CRV diagnostic workflow to aid early detection. Our results emphasize the importance of vigilance for neurological symptoms in RA patients and highlight the need for future research to optimize treatment protocols and reduce long-term disability.